Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06345638 · ClinicalTrials.gov registry record
Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 52
- Enrollment target
NCT06345638: Completed study, sponsored by University of Pennsylvania.
NCT06345638 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 52 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06345638 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
This study aims to characterize sex differences in the pathophysiology of vaso-occlusive crises (VOC) occurring among individuals with sickle cell disease (SCD). * The study will compare CRP and other biomarkers between females with SCD in the follicular phase of the menstrual cycle and males with SCD. * The study will explore potential sex differences in biomarker changes between females and males with SCD during and following resolution of VOC. * The study will compare neutrophil and platelet adhesion to the endothelium and real time fibrin deposition in the blood.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2025-06-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06345638
The ClinicalTrials.gov registry entry for NCT06345638 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06345638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06345638 about?
NCT06345638 is a clinical study titled "Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease". This study aims to characterize sex differences in the pathophysiology of vaso-occlusive crises (VOC) occurring among individuals with sickle cell disease (SCD). * The study will compare CRP and other biomarkers between females with SCD in the follicular phase of the menstrual cycle and males with ...
What is the current status of trial NCT06345638?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2024-03-01. Estimated completion is 2025-06-17.
Who is sponsoring clinical trial NCT06345638?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.